Cargando…
Comparing Additionality of Tuberculosis Cases Using GeneXpert or Smear-Based Active TB Case-Finding Strategies among Social Contacts of Index Cases in Nepal
This study compares the yield and additionality of community-based active tuberculosis (TB) active case-finding strategies using either smear microscopy or GeneXpert as the TB diagnostic test. Active case-finding strategies screened social contacts of index cases and high-risk groups in four distric...
Autores principales: | Gurung, Suman Chandra, Dixit, Kritika, Paudel, Rajan, Sah, Manoj Kumar, Pandit, Ram Narayan, Aryal, Tara Prasad, Khatiwada, Shikha Upadhyay, Majhi, Govind, Dhital, Raghu, Paudel, Puskar Raj, Shrestha, Gyanendra, Rai, Bhola, Budhathoki, Gangaram, Khanal, Mukti, Mishra, Gokul, Levy, Jens, Van de Rest, Job, Thapa, Anchal, Ramsay, Andrew, Squire, Stephen Bertel, Lönnroth, Knut, Basnyat, Buddha, Caws, Maxine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384436/ https://www.ncbi.nlm.nih.gov/pubmed/37505665 http://dx.doi.org/10.3390/tropicalmed8070369 |
Ejemplares similares
-
Comparative Yield of Tuberculosis during Active Case Finding Using GeneXpert or Smear Microscopy for Diagnostic Testing in Nepal: A Cross-Sectional Study
por: Gurung, Suman Chandra, et al.
Publicado: (2021) -
The role of active case finding in reducing patient incurred catastrophic costs for tuberculosis in Nepal
por: Gurung, Suman Chandra, et al.
Publicado: (2019) -
Protocol for the Addressing the Social Determinants and Consequences of Tuberculosis in Nepal (ASCOT) pilot trial
por: Rai, Bhola, et al.
Publicado: (2022) -
Developing Feasible, Locally Appropriate Socioeconomic Support for TB-Affected Households in Nepal
por: Rai, Bhola, et al.
Publicado: (2020) -
Research protocol for a mixed-methods study to characterise and address the socioeconomic impact of accessing TB diagnosis and care in Nepal
por: Dixit, Kritika, et al.
Publicado: (2020)